Antioxidant shown to reduce blindness risk in extremely premature babies

Retinopathy of prematurity (ROP) is the second most common cause of childhood blindness in the United States, occurring in half of premature infants born earlier than or at 28 weeks gestational age. The condition is caused by abnormal blood vessel development in the retina of the eye. ROP risk increases with decreasing gestational age.

A study by researchers at Brigham and Women's Hospital (BWH) suggests that the antioxidant, rhSOD (recombinant human Cu/Zn superoxide dismutase), reduces the risk of developing ROP in extremely low newborns.

The post-hoc analysis study will be published online on June 15, 2012 in Neonatology.

Researchers looked at a subset of data from a previous multicenter trial that randomized 302 to receive either rhSOD or placebo for prevention of bronchopulmonary dysplasia (a chronic lung condition that affects newborn babies). Researchers analyzed the data looking specifically at the incidence and severity of ROP in extremely low gestational age newborns.

Within the entire cohort, there were no significant differences in ROP in newborns given placebo versus those given rhSOD. However, those born earlier than 26 weeks (72 babies) had a 22 percent reduction in ROP. The abnormality was reduced by 53 percent for babies born earlier than 25 weeks (24 babies).

"Even though strides have been made in developing interventions to stop ROP from progressing to blindness, there are currently no therapies available for ROP prevention," said Richard Parad, MD, BWH Department of Newborn Medicine, lead study author. "There is a large need for the preventive approach that rhSOD could potentially provide."

The researchers note that while looking at ROP was not the primary outcome for which the prior study was designed, this post-hoc analysis was carefully re-focused on the tiniest babies with the highest ROP risk based on recent advances in the understanding of how ROP develops and on evidence from prior studies of other antioxidants that suggested such agents might interfere with development of ROP.

In light of the findings, the researchers stress that further studies are required to confirm their observations.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Youth are quietly losing their hearing

Aug 27, 2014

Children and teens constantly plugged into personal listening devices, such as phones, computers or music players, could be harming their ears without realizing it, says a Purdue University audiologist.

Quality childcare leads to benefits at school age

Aug 26, 2014

(Medical Xpress)—Children who receive a quality childcare experience at age 2-3 are more likely to be attentive and better able to deal with their emotions as they start school, according to new research from the University ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Tom_Hennessy
not rated yet Jun 15, 2012
Vitamin E was proposed for this problem long ago.
J Pediatr. 1997 Dec;131(6):844-50.

"CONCLUSIONS: Considering that there was a 52% reduction in the incidence of Stage 3 ROP, we suggest that the role of vitamin E in reducing severe ROP be re-evaluated"